Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations

Схожие документы

• A precision medicine classification for treatment of acute myeloid leukemia in older patients
  по: Mims, Alice S., et al.
  Опубликовано: (2021)
• Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21
  по: Bhatnagar, Bhavana, et al.
  Опубликовано: (2019)
• Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
  по: Bhatnagar, Bhavana, et al.
  Опубликовано: (2016)
• Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A
  по: Bill, Marius, et al.
  Опубликовано: (2020)
• NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
  по: Eisfeld, Ann-Kathrin, et al.
  Опубликовано: (2018)